Adams Labs Mucinex Marketing Strategy Targeting Healthcare Professionals
This article was originally published in The Tan Sheet
Executive Summary
Adams Laboratories plans to launch Mucinex "long-acting" guaifenesin tablets with a behind-the-counter sales strategy
You may also be interested in...
Adams May Cough Up Humibid As Product Confusion Congests Sales
Adams Respiratory Therapeutics is considering whether to stop offering its Humibid 1,200 mg guaifenesin product, which it markets voluntarily behind the counter, as it launches an over-the-counter version of the same product under the name Maximum Strength Mucinex
Adams May Cough Up Humibid As Product Confusion Congests Sales
Adams Respiratory Therapeutics is considering whether to stop offering its Humibid 1,200 mg guaifenesin product, which it markets voluntarily behind the counter, as it launches an over-the-counter version of the same product under the name Maximum Strength Mucinex
Adams May Cough Up Humibid As Product Confusion Congests Sales
Adams Respiratory Therapeutics is considering whether to stop offering its Humibid 1,200 mg guaifenesin product, which it markets voluntarily behind the counter, as it launches an over-the-counter version of the same product under the name Maximum Strength Mucinex